712 filings
Page 2 of 36
6-K
i0pql6zz9 0x3t2
11 Oct 23
Kazia Announces Voluntary Delisting from Asx
7:35am
6-K
481f0jkifmdbo
10 Oct 23
Current report (foreign)
3:04pm
6-K
74hrq
6 Oct 23
Current report (foreign)
7:00am
6-K
pcl8wc 88lq8
29 Sep 23
Kazia Therapeutics Announces Acceptance of
7:00am
6-K
ekx905f4h7ho7y7
5 Sep 23
Current report (foreign)
7:02am
6-K
plvlv 8rrna7mws
11 Aug 23
Kazia Therapeutics Announces Change to Board of Directors
7:00am
6-K
60b7 cd9wcd
6 Jul 23
Current report (foreign)
4:15pm
6-K
hm9aw v7a
26 Jun 23
Kazia Corporate Update and Corporate Presentation
7:00am
6-K
ue7wq
5 Jun 23
Kazia Expands Board of Directors with Appointment of Ebru Davidson
7:35am
6-K
loa mgtpn8zeguhu
1 May 23
Kazia Announces Executive Leadership Changes
7:14am
6-K
gogixsf
14 Apr 23
Current report (foreign)
7:49am
6-K
6gd d4sdne
4 Apr 23
Kazia Presents New Data for Paxalisib and EVT801
7:32am
6-K/A
zpdl463ebi9w3ke0qt
9 Mar 23
2. Results for announcement to the market
7:32am
6-K
xubejf0d
7 Mar 23
Kazia Therapeutics Announces Clinical Collaboration for Australian Phase Ii Precision Medicine Study of Paxalisib In Childhood Cancers
7:40am
6-K
nxhg l1ness9ub0el
28 Feb 23
2. Results for announcement to the market
4:18pm
6-K
15dhao5p j0
24 Feb 23
Results of Egm
4:30pm
6-K
rf3pyqw 7lu
24 Feb 23
Current report (foreign)
7:35am
6-K
rr4l4
20 Jan 23
Current report (foreign)
7:59am
6-K
on89a97h wpk
17 Jan 23
Current report (foreign)
8:24am
6-K
xcu8pyc
15 Dec 22
Kazia Launches Preclinical Collaboration with Qimr Berghofer Medical Research Institute and Announces Patent Filing
7:45am